Site-directed modification of FVIII

Details for Australian Patent Application No. 2005304622 (hide)

Owner Bayer Healthcare LLC

Inventors Pan, Clark Q.; Chen, Jianmin; Murphy, John E.; Wang, Deqian; Strauss, Jonathan S.; Tang, Liang; Barnett, Thomas; Tjandra, Hendri; Mei, Baisong

Agent Davies Collison Cave

Pub. Number AU-B-2005304622

PCT Pub. Number WO2006/053299

Priority 60/627,277 12.11.04 US

Filing date 14 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 29 March 2012

International Classifications

C07K 14/755 (2006.01) Peptides having more than 20 amino acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/053299 Priority application(s): WO2006/053299

29 March 2012 Application Accepted

  Published as AU-B-2005304622

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304624-Fc variants with altered binding to FcRn

2005304620-Toughened polyamide for food packaging and health care applications